Clinicopathological and Prognostic Significance of Inhibitor of Apoptosis Protein (IAP) Family Members in Lung Cancer: A Meta-Analysis
@article{Fung2021ClinicopathologicalAP, title={Clinicopathological and Prognostic Significance of Inhibitor of Apoptosis Protein (IAP) Family Members in Lung Cancer: A Meta-Analysis}, author={Stephen Fung and Wolfram Trudo Knoefel and Andreas Krieg}, journal={Cancers}, year={2021}, volume={13} }
Simple Summary Lung cancer is the leading cause of cancer-related death worldwide. Although novel therapy regimens using immuno- and targeted therapy have improved survival for a subgroup of patients with lung cancer, the five-year survival rate is still poor. The inhibitor of apoptosis protein (IAP) family represents a heterogeneous group of anti-apoptotic proteins that are highly expressed in a variety of human malignancies. Despite conflicting results regarding the prognostic significance of…
Figures and Tables from this paper
One Citation
Nuclear survivin is a prognosticator in gastroenteropancreatic neuroendocrine neoplasms: a meta-analysis
- BiologyJournal of Cancer Research and Clinical Oncology
- 2022
Gastroenteropancreatic neuroendocrine neosplasms (GEP-NEN) are biologically heterogenous tumors with an increasing incidence over the past decades. Although efforts have been made in the treatment of…
References
SHOWING 1-10 OF 119 REFERENCES
Expression of X-linked inhibitor of apoptosis as a novel prognostic marker in radically resected non-small cell lung cancer patients.
- Medicine, BiologyClinical cancer research : an official journal of the American Association for Cancer Research
- 2001
The unexpected inverse correlation of XIAP with proliferation markers and the absence of correlation with apoptotic index, coupled with its role as an independent positive prognostic factor for survival in radically resected NSCLC patients imply a more complex role for XIAP in tumor biology than anticipated by in vitro data.
Nuclear and cytoplasmic cellular distribution of survivin as survival predictor in resected non-small-cell lung cancer.
- Medicine, BiologyEuropean journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
- 2008
Expression of inhibitors of apoptosis (IAP) proteins in non-small cell human lung cancer
- Medicine, BiologyJournal of Cancer Research and Clinical Oncology
- 2002
The results indicate an involvement of the anti-apoptotic XIAP in pathogenesis of NSCLC, while hIAP-1 preferentially seems to play an important role in low-stage adenocarcinoma.
Nuclear localization of survivin is a positive prognostic factor for survival in advanced non-small-cell lung cancer.
- Medicine, BiologyAnnals of oncology : official journal of the European Society for Medical Oncology
- 2004
Results indicate that differential localization of survivin may be a prognostic factor for NSCLC and Interestingly, nuclear survivin levels predicted longer overall and relapse-free survival, in univariate and multivariate analyses.
Nuclear survivin in pN2 nonsmall cell lung cancer: prognostic and clinical implications
- MedicineEuropean Respiratory Journal
- 2009
It is concluded that nuclear survivin is strongly related to lymph node metastasis and proliferative potentials in pathological N2 nonsmall cell lung cancer patients.
The role of survivin on overall survival of non-small cell lung cancer, a meta-analysis of published literatures.
- MedicineLung cancer
- 2008
Elevated Expression of BIRC6 Protein in Non–Small-Cell Lung Cancers is Associated with Cancer Recurrence and Chemoresistance
- Biology, MedicineJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
- 2013
Elevated BIRC6 protein expression in NSCLC tissues was associated with poor 3-year relapse-free patient survival, lymph node involvement, and advanced pathological tumor, node, metastasis stage, and down-regulation of the BIRC 6 gene as a therapeutic approach may be effective, especially in combination with conventional chemotherapeutics.
Survivin expression is an independent poor prognostic marker in lung adenocarcinoma but not in squamous cell carcinoma
- MedicineVirchows Archiv
- 2013
It is suggested that survivin is an independent negative prognostic factor in adenocarcinoma, but not in squamous cell carcinoma, which highlights the biological differences between these two histologic types.
Significance of survivin expression: Prognostic value and survival in stage III non-small cell lung cancer.
- MedicineExperimental and therapeutic medicine
- 2012
The 5-year survival rate of patients with positive survivin expression was significantly lower compared with the survivin-negative cancer patients (P<0.05), and the expression of survivin in NSCLC correlated with tumor size.
A multiple marker analysis of apoptosis-associated protein expression in non-small cell lung cancer in a Chinese population.
- Biology, MedicineFolia histochemica et cytobiologica
- 2011
It is indicated that apoptosis- -associated proteins may impact a variety of clinicopathological features of NSCLC and may co-operatively influence the prognosis of patients with this malignant tumor.